Evidence map›Paper›PMID 31792836›Full record

ArticleMolecular imaging and biology2020

Relationship Between Tumor Immune Markers and Fluorine-18-α-Methyltyrosine ([

Kimihiro Shimizu, Kyoichi Kaira, Tetsuya Higuchi, Takeshi Hisada, Takehiko Yokobori, Tetsunari Oyama, Takayuki Asao, Yoshito Tsushima, Ken Shirabe

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. CD98 Light Chain LAT1 Tracers in PET-CT Diagnosis of Cancer Patients.Anti-cancer agents in medicinal chemistry · 2026
    Review
  2. Tumor infiltrating lymphocytes and radiological picture of the tumor.Medical oncology (Northwood, London, England) · 2023
    Review
  3. Review
  4. Enzymatic synthesis of fluorinated compounds.Applied microbiology and biotechnology · 2021
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kimihiro ShimizuDepartment of General Surgical Science, Gunma University, Graduate School of Medicine, Maebashi, Gunma, Japan.
Kyoichi KairaDepartment of General Surgical Science, Gunma University, Graduate School of Medicine, Maebashi, Gunma, Japan. kkaira1970@yahoo.co.jp.
Tetsuya HiguchiDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University, Graduate School of Medicine, Maebashi, Gunma, Japan.
Takeshi HisadaDepartment of Respiratory Medicine, Gunma University, Graduate School of Medicine, Maebashi, Gunma, Japan.
Takehiko YokoboriDepartment of Innovative Immune-Oncology Therapeutics, Gunma University, Graduate School of Medicine, Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Tetsunari OyamaDepartment of Diagnostic Pathology, Gunma University, Graduate School of Medicine, Maebashi, Gunma, Japan.
Takayuki AsaoBig Data Center for Integrative Analysis, Gunma University Initiative for Advanced Research, Maebashi, Japan.
Yoshito TsushimaDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University, Graduate School of Medicine, Maebashi, Gunma, Japan.
Ken ShirabeDepartment of General Surgical Science, Gunma University, Graduate School of Medicine, Maebashi, Gunma, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose3-[ PROCEDURES: A total of 75 patients with NSCLC who underwent [

resultsHigh uptake of [

conclusionsThe uptake of [

Indexed as

AdultAgedAged, 80 and overalpha-MethyltyrosineAnalysis of VarianceB7-H1 AntigenBiomarkers, TumorFemaleFluorine RadioisotopesHumansLung NeoplasmsMaleMiddle AgedPositron-Emission TomographyROC Curvealpha-MethyltyrosineB7-H1 AntigenBiomarkers, TumorFluorine-18Fluorine Radioisotopes[18F]FAMT PETAmino acid metabolismLung cancerPD-L1Tumor immune markers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.